Should a history of gallstones be a contraindication for GLP1-RA or should a provider use caution
8.5 Geriatric Use In the pool of glycemic control trials, 1,229 (30%) patients treated with semaglutide tablets were 65 years of age and over and 199 (5%) patients treated with semaglutide tablets were 75 years of age and over [see Clinical Studies (14)]
Prolonged daily use increases the risk of the onset of symptoms as rash, hives, itching, swelling, hoarseness, difficulty in breathing and also of more severe complications as stomach bleeding, kidney or liver damage, thrombocytopenia, leukopenia, anemia, agranulocytosis, epidermal necrolisys, multiform erythema, Steven-Jhonsons syndrome
The strongest angle is indirect: by supporting sleep quality and restorative biological processes, Epitalon may be relevant to recovery-focused wellness routines